DOI:
10.1055/s-00000005
Aktuelle Rheumatologie
LinksClose Window
References
Aringer M, Burkhardt H, Burmester GR et al.
Current state of evidence on ‘off-label’ therapeutic options for systemic lupus erythematosus, including biological immunosuppressive agents, in Germany, Austria and Switzerland – a consensus report.
Lupus 2012;
21: 386-401
We do not assume any responsibility for the contents of the web pages of other providers.